Playback speed
10 seconds
PI3K Inhibitors Are Highly Active in R/R Follicular Lymphoma, New Dosing Strategies May Improve Tolerance Without Sacrificing Efficacy
115 views
March 4, 2020
Login to view comments.
Click here to Login